---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-010995"
form_type: "8-K"
ticker: "ANIX"
cik: "0000715446"
company_name: "Anixa Biosciences Inc"
filed_at: "2024-03-22T23:59:59+00:00"
generated_at: "2026-06-04T09:22:10.624868+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Anixa Biosciences re-elects four directors and ratifies auditor at 2024 annual meeting

## Summary
- Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. re-elected as directors with 7.9M-7.7M votes for.
- Executive compensation approved on non-binding advisory basis: 6.0M for, 1.8M against, 123K abstain.
- Haskell & White LLP ratified as independent auditor for FY ending Oct 31, 2024: 18.4M for, 80K against, 51K abstain.
- Total shares present at meeting: 18,521,786 out of 31,711,753 eligible shares (58.4% turnout).

## SEC filing metadata
- accession: 0001493152-24-010995
- form_type: 8-K
- ticker: ANIX
- cik: 0000715446
- company_name: Anixa Biosciences Inc
- filed_at: 2024-03-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/715446/000149315224010995/0001493152-24-010995-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/715446/000149315224010995/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-010995
- JSON: https://secwatch.observer/filing/0001493152-24-010995.json
- Plain text: https://secwatch.observer/filing/0001493152-24-010995.txt

## Key facts
- Shareholder Votes
  Anixa Biosciences Inc shareholders approved Approval, by non-binding advisory vote, of the Company's executive compensation at the 2024-03-21 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2024-03-21
  source text: The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 6,010,385 1,843,353 123,415 10,544,633
  evidence_url: https://www.sec.gov/Archives/edgar/data/715446/000149315224010995/0001493152-24-010995-index.htm
- Shareholder Votes
  Anixa Biosciences Inc shareholders approved Ratification of the appointment of independent registered public accounting firm at the 2024-03-21 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-03-21
  source text: The voting results were as follows: Shares Voted For Shares Voted Against Shares Abstaining Broker Non-Vote 18,390,227 80,392 51,167 -
  evidence_url: https://www.sec.gov/Archives/edgar/data/715446/000149315224010995/0001493152-24-010995-index.htm
- Shareholder Votes
  Anixa Biosciences Inc shareholders approved Election of directors at the 2024-03-21 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-03-21
  source text: The voting results were as follows: Nominee Shares Voted For Shares Withheld Broker Non-Vote Dr. Amit Kumar 7,894,499 82,654 10,544,633 Dr. Arnold Baskies 7,857,006 120,147 10,544,633 Emily Gottschalk 7,853,085 124,068 10,544,633 Lewis H. Titterton, Jr. 7,718,162 258,991 10,544,633
  evidence_url: https://www.sec.gov/Archives/edgar/data/715446/000149315224010995/0001493152-24-010995-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.